ES71
TEAS SECTION 71 RECEIVED
30/07/2026
Voltar para busca
Dado oficial do USPTO
SAMSUNG BIOEPIS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
64
Atualização mais recente
30/07/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
08/09/2014
Data de registro
02/08/2016
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
18/11/2022
Última transação
30/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
Jung-gu, KR
Examinador
CROWLEY, SEAN MICHAEL
Unidade examinadora
M70
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
Samsung C&T Corporation
Cheil Industries Inc.
Samsung C&T Corporation
Representantes
Stephen R. Barrese Dilworth & Barrese, LLP
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Chemicalbiologicalantibody and protein formulations being pharmaceuticals for the treatment of immunologic disordersautoimmune diseasesinflammatory diseasesarthritiscancertumorcentral nervous system disorders or metabolic diseases; anti-cancer agents; preparations for treatment of immune diseases; preparations for treatment of arthritis; preparation for treatment of ophthalmologic diseases; preparation for treatment of circulatory disorders; preparation for treatment of nervous system disorders; sanitary preparations for medical purposes; food for babies; dietary supplements for humans and animals; material for stopping teethdental wax; preparations for destroying vermin; fungicidesherbicides
Publicações
Histórico de despachos e eventos da marca no USPTO.
64 publicações encontradas
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
02/08/2025
RNWL
INTERNATIONAL REGISTRATION RENEWED
10/10/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
20/09/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/06/2024
NA15
SEC. 15 ACKNOWLEDGEMENT - E-MAILED
18/11/2022
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - MAILED
18/11/2022
71AG
REGISTERED-SEC.71 ACCEPTED
18/11/2022
15AK
REGISTERED - SEC. 15 ACKNOWLEDGED
18/11/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/11/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/10/2022
E15R
TEAS SECTION 15 RECEIVED
03/08/2022
ES71
TEAS SECTION 71 RECEIVED
02/08/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
25/03/2022
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
02/08/2021
GPNX
NOTIFICATION PROCESSED BY IB
16/06/2017
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
16/06/2017
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
15/06/2017
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/05/2017
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
30/03/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
30/11/2016
FIMP
FINAL DISPOSITION PROCESSED
30/11/2016
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/11/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
02/08/2016
CHLD
CHANGE OF OWNER RECEIVED FROM IB
16/06/2016
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
18/05/2016
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
18/05/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17/05/2016
PUBO
PUBLISHED FOR OPPOSITION
17/05/2016
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
27/04/2016
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
27/04/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
27/04/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
14/04/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
14/04/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
13/04/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/04/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/04/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/04/2016
RFNT
REFUSAL PROCESSED BY IB
01/04/2016
CNRT
NON-FINAL ACTION MAILED
08/02/2016
CNRT
NON-FINAL ACTION WRITTEN
06/02/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/01/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/01/2016
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
12/01/2016
CNFR
FINAL REFUSAL MAILED
22/07/2015
CNFR
FINAL REFUSAL WRITTEN
21/07/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/06/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/06/2015
ALIE
ASSIGNED TO LIE
15/06/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/06/2015
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
18/01/2015
RFNT
REFUSAL PROCESSED BY IB
27/12/2014
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
19/12/2014
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/12/2014
RFRR
REFUSAL PROCESSED BY MPU
09/12/2014
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/12/2014
CNRT
NON-FINAL ACTION WRITTEN
07/12/2014
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
14/11/2014
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
13/11/2014
CNRT
NON-FINAL ACTION WRITTEN
12/11/2014
MAFR
APPLICATION FILING RECEIPT MAILED
07/11/2014
DOCK
ASSIGNED TO EXAMINER
06/11/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/11/2014
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
23/10/2014
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SAMSUNG BIOEPIS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.